DARE (Dare Bioscience) Cyclically Adjusted FCF per Share: $34.03 (As of Mar. 2026)


DARE Dare Bioscience Inc DARE
21 GF Score
Price $2.03
! 4 Warning Signs
View Full Analysis

What is Dare Bioscience Cyclically Adjusted FCF per Share?

Dare Bioscience DARE -0.50% 21 Cyclically Adjusted FCF per Share is $34.03 as of Mar. 2026. GuruFocus rates DARE with a GF Score™ of 21/100. The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Dare Bioscience's adjusted free cash flow per share for the three months ended in Mar. 2026 was $-0.380. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is $34.03 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Dare Bioscience's average Cyclically Adjusted FCF Growth Rate was 220.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

As of today (2026-07-08), Dare Bioscience's current stock price is $2.03. Dare Bioscience's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2026 was $34.03. Dare Bioscience's Cyclically Adjusted Price-to-FCF of today is 0.06.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Dare Bioscience was 0.79. The lowest was 0.05. And the median was 0.12.


Dare Bioscience  (NAS:DARE) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Dare Bioscience's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=2.03/34.03
=0.06

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Dare Bioscience was 0.79. The lowest was 0.05. And the median was 0.12.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Dare Bioscience Cyclically Adjusted FCF per Share Related Terms


Dare Bioscience Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Dare Bioscience's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dare Bioscience Cyclically Adjusted FCF per Share Chart

Dare Bioscience Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 -289.33 -11.53 4.27 25.30

Dare Bioscience Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.61 15.43 20.33 25.30 34.03

DARE vs ATNM, NNVC, LSTA: Cyclically Adjusted FCF per Share Comparison

For the Biotechnology subindustry, Dare Bioscience's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dare Bioscience Cyclically Adjusted Price-to-FCF vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Dare Bioscience's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Dare Bioscience's Cyclically Adjusted Price-to-FCF falls into.


DARE
21GF Score
Dare Bioscience Inc DARE
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Dare Bioscience Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Dare Bioscience's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.38/330.2130*330.2130
=-0.380

Current CPI (Mar. 2026) = 330.2130.

Dare Bioscience Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201606 -49.798 241.018 -68.227
201609 352.116 241.428 481.606
201612 -2.288 241.432 -3.129
201703 -0.671 243.801 -0.909
201706 -1.447 244.955 -1.951
201709 -3.411 246.819 -4.563
201712 -1.907 246.524 -2.554
201803 -2.927 249.554 -3.873
201806 -2.825 251.989 -3.702
201809 -2.890 252.439 -3.780
201812 -2.847 251.233 -3.742
201903 -3.475 254.202 -4.514
201906 -2.249 256.143 -2.899
201909 -2.288 256.759 -2.943
201912 -2.533 256.974 -3.255
202003 -3.327 258.115 -4.256
202006 -1.836 257.797 -2.352
202009 -2.035 260.280 -2.582
202012 -2.887 260.474 -3.660
202103 -2.259 264.877 -2.816
202106 -2.805 271.696 -3.409
202109 0.224 274.310 0.270
202112 -2.287 278.802 -2.709
202203 -1.765 287.504 -2.027
202206 -1.188 296.311 -1.324
202209 1.209 296.808 1.345
202212 -0.867 296.797 -0.965
202303 -2.262 301.836 -2.475
202306 -0.914 305.109 -0.989
202309 -1.051 307.789 -1.128
202312 -1.121 306.746 -1.207
202403 -0.814 312.332 -0.861
202406 1.489 314.175 1.565
202409 -0.661 315.301 -0.692
202412 0.591 315.605 0.618
202503 -0.643 319.799 -0.664
202506 -0.593 322.561 -0.607
202509 -0.048 324.800 -0.049
202512 0.087 324.054 0.089
202603 -0.380 330.213 -0.380

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of $34.03 mean?
Dare Bioscience (DARE) has a Cyclically Adjusted FCF per Share of $34.03 as of Mar. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Dare Bioscience and its competitors.
Is Dare Bioscience's Cyclically Adjusted FCF per Share too high?
Dare Bioscience's current Cyclically Adjusted FCF per Share is $34.03. Overall, Dare Bioscience has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Dare Bioscience's Cyclically Adjusted FCF per Share compare to ATNM and NNVC?
Dare Bioscience's Cyclically Adjusted FCF per Share of $34.03 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Biotechnology company?
A good Cyclically Adjusted FCF per Share depends on the Biotechnology industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Dare Bioscience and its competitors. Dare Bioscience's current Cyclically Adjusted FCF per Share is $34.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dare Bioscience stock overvalued right now?
Dare Bioscience (DARE) has a current Cyclically Adjusted FCF per Share of $34.03. The current Cyclically Adjusted FCF per Share is $34.03. Dare Bioscience's overall GF Score™ is 21/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Dare Bioscience (DARE), the current Cyclically Adjusted FCF per Share is $34.03 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Dare Bioscience Business Description

Address 3655 Nobel Drive, Suite 260, San Diego, CA, USA, 92122
Dare Bioscience Inc is a biopharmaceutical company committed to advancing products for women's health. The company identifies, develops, and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.
21GF Score

Get the complete analysis for DARE

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.03
Price